Peregrine Pharmaceuticals, Inc. operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Peregrine Pharmaceuticals with three other
pharmaceutical manufacturers in North America:
Integrated Biopharma, Inc.
sales of $42.21 million
China Yct International Group, Inc.
Corium International Inc
of which 100%
Peregrine Pharmaceuticals reported sales of $44.69 million
April of 2016.
increase of 66.9%
versus 2015, when the company's sales were $26.78 million.
Sales at Peregrine Pharmaceuticals have increased during each of the previous five years
(and since 2011, sales have increased a total of 231%).
Sales of Contract Manufacturing and Development O saw an increase
65.9% in 2016, from
$26.74 million to $44.36 million.